Recent advances in treatments of adult immune thrombocytopenia
Author:
Open Access
- 30 April 2022
- journal article
- review article
- Published by Springer Nature in Blood Research
- Vol. 57 (S1) , S112-S119
Abstract
Dae Sik Kim. Blood Res 2022;57:S112-9. https://doi.org/10.5045/br.2022.2022038Keywords
This publication has 73 references indexed in Scilit:
- Cellular immune dysfunction in immune thrombocytopenia (ITP)British Journal of Haematology, 2013
- Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopeniaBlood, 2013
- Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND studyBlood, 2013
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cellsJournal of Clinical Investigation, 2012
- Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopeniaBlood, 2012
- Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in miceBlood, 2012
- Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agentsBlood, 2010
- Romiplostim or Standard of Care in Patients with Immune ThrombocytopeniaNew England Journal of Medicine, 2010
- The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reportsAmerican Journal of Hematology, 2010
- FcRn: the neonatal Fc receptor comes of ageNature Reviews Immunology, 2007